Spore is business intelligence built on the data Celium already holds for you: every sale, every customer, every unit of stock, across your store and Takealot.
It watches the numbers overnight, flags what is growing and what is stalling, answers your questions in plain language, and can draft the campaign to act on it, from your own product photos.
Revenue, orders, repeat customers and stock, for your store and Takealot, each shown on its own so nothing gets double-counted.
Every night Spore looks for what changed: products taking off, products stalling, stock that will run out, pairs that sell together, channels you are under-using. You wake up to a short list.
Ask it what to push, who buys what, or why a month dipped. It answers from your real numbers, not general advice, and shows the figures it used.
Turn an opportunity into an experiment with a clear goal, then record what you learnt. Spore keeps the learnings and uses them the next time it makes a suggestion.
The Spore studio drafts on-brand Instagram posts and carousels from your own product photos and brand kit, writes the captions, and schedules them. You approve before anything goes out.
Spore reads your organisation's sales, customers and stock and nothing else. Internal transfers, packaging and consumables are kept out so the numbers mean what they say.
There is nothing to import. If you sell through Celium, the data is already there.
Orders from your Shopify, Wix or WooCommerce store and Takealot already land in Celium. Spore reads them, along with your stock and product photos.
Each night it compares the last 30 days to the 30 before, checks stock against sales pace, and writes up what it found as plain-language opportunities.
Dismiss it, turn it into an experiment, or ask for a campaign. Anything that touches customers waits for your approval first.
Spore runs on the sales history Celium already has for you, so the more you sell through Celium, the more it has to work with. If you would like to be in the first group, tell us which channels you sell on.
Ask about early access →